Breaking News - The Fly

Open Search

CELU

Celularity

$

()

Celularity Q1 sales are trending ahead of expectations

CELU

4/15/2024 - 08:07am

Celularity data showing senescent cell elimination to be presented at ASGCT

CELU

4/8/2024 - 09:09am

Celularity receives HCPCS Q code approval from U.S. CMS for Biovance 3L

CELU

3/26/2024 - 09:07am

Celularity submits request to FDA for orphan drug designation for PDA-002

CELU

3/20/2024 - 09:16am

Celularity to present in vivo data from T-cell therapy platform at AACR

CELU

3/7/2024 - 09:36am

Celularity trading halted, news pending

CELU

2/28/2024 - 19:50pm

Celularity announces 1-for-10 reverse stock split

CELU

2/23/2024 - 16:13pm

Celularity sees FY24 net sales of biomaterial product, biobanking $50M-$56M

CELU

2/1/2024 - 09:08am

Celularity sees Q1 net sales of biomaterial product, biobanking $10.25M-$11.5M

CELU

2/1/2024 - 09:08am

Celularity comments on closing $21M financing transactions

CELU

1/25/2024 - 09:09am

Celularity confirms commercialization agreement with BioCellgraft

CELU

1/4/2024 - 13:01pm

Celularity receives noncompliance notification from Nasdaq

CELU

11/24/2023 - 13:59pm

Celularity announces biomaterial products receive SFDA classification

CELU

10/18/2023 - 09:04am

Celularity enters Research Collaboration Services Agreement with Regeneron

CELU , REGN

8/29/2023 - 09:10am

Celularity announces $3M registered direct offering

CELU

7/27/2023 - 09:10am